Lightbridge (LTBR)
NASDAQ:LTBR
Want to see LTBR full AI Analyst Report?
Top Page
Lightbridge
(NASDAQ:LTBR)
Select Model
Select Model
Rating:49Neutral
Price Target:
$13.00
▼(-14.30% Downside)
Action:ReiteratedDate:04/28/26
Overall score is held down primarily by weak financial performance (no revenue, widening losses, and ongoing cash burn). The earnings call provides a meaningful offset via improved funding/runway and tangible technical milestones, while technical indicators are moderately supportive near-term but weaker longer-term; valuation remains constrained by losses and no dividend support.
Positive Factors
Intellectual Property Expansion
A granted European allowance broadens Lightbridge’s IP rights across major nuclear markets, strengthening a durable barrier to entry. Extended protection for multi-zone and additive manufacturing claims supports licensing leverage with fabricators and utilities over multi-year commercialization efforts.
Negative Factors
Pre-Commercial Status
Being pre-revenue means core commercial economics are unproven; licensing and royalty models hinge on successful qualification and customer adoption. Persistent lack of sales creates execution risk that could extend cash consumption timelines absent timely deployment agreements.
Read all positive and negative factors
Positive Factors
Negative Factors
Intellectual Property Expansion
A granted European allowance broadens Lightbridge’s IP rights across major nuclear markets, strengthening a durable barrier to entry. Extended protection for multi-zone and additive manufacturing claims supports licensing leverage with fabricators and utilities over multi-year commercialization efforts.
Read all positive factors
Lightbridge (LTBR) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$398.30M
Dividend YieldN/A
Average Volume (3M)834.91K
Price to Earnings (P/E)―
Beta (1Y)2.42
Revenue GrowthN/A
EPS Growth4.53%
CountryUS
Employees10
SectorIndustrials
Sector Strength72
IndustryElectrical Equipment & Parts
Share Statistics
EPS (TTM)-0.20
Shares Outstanding34,651,580
10 Day Avg. Volume766,268
30 Day Avg. Volume834,910
Financial Highlights & Ratios
PEG Ratio12.82
Price to Book (P/B)1.53
Price to Sales (P/S)0.00
P/FCF Ratio-21.70
Enterprise Value/Market Cap0.20
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-6.73
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Lightbridge Business Overview & Revenue Model
Company Description
Lightbridge Corporation, together with its subsidiaries, engages in the design and development of nuclear fuel technology under the Lightbridge Fuel name. It focuses on developing and commercializing metallic nuclear fuels that could enhance resis...
How the Company Makes Money
Lightbridge’s business model is centered on commercializing its nuclear fuel technology through licensing and related arrangements with established participants in the nuclear fuel supply chain. The company aims to generate revenue primarily from ...
Lightbridge Earnings Call Summary
Earnings Call Date:Feb 25, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Aug 17, 2026
Earnings Call Sentiment Positive
The call conveyed strong technical progress and a materially improved financial position, highlighted by the start of ATR irradiation testing, validated fabrication milestones, expanded INL scope and technical publications, and a cash balance that increased to $201.9 million (approximately +405% year-over-year) funded largely by a $176.0 million equity raise. At the same time, the company remains pre-commercial with significant regulatory, testing, and licensing work still required, used $14.3 million in operations in fiscal 2025, and faces timeline and execution risks tied to future post-irradiation examination and NRC engagement. Overall, positive execution and funding momentum outweigh near-term development and regulatory uncertainties.Positive Updates
Irradiation Testing Commenced at Idaho National Laboratory
Began irradiation testing of enriched uranium-zirconium alloy fuel material samples in the Advanced Test Reactor (ATR) at Idaho National Laboratory (November 2025). This is a pivotal technical milestone to generate burnup-dependent data for fuel behavior modeling and regulatory licensing; initial partially irradiated samples expected to be removed in April–May for post-irradiation examination.
Negative Updates
Pre-Commercial Stage and No Reported Product Revenue
Company remains in development and testing phase with no commercial sales reported on the call; critical work remains on fuel performance testing and regulatory qualification prior to commercialization, exposing the company to execution and timeline risk.
Read all updates
Q4-2025 Updates
Positive
Negative
Irradiation Testing Commenced at Idaho National Laboratory
Began irradiation testing of enriched uranium-zirconium alloy fuel material samples in the Advanced Test Reactor (ATR) at Idaho National Laboratory (November 2025). This is a pivotal technical milestone to generate burnup-dependent data for fuel behavior modeling and regulatory licensing; initial partially irradiated samples expected to be removed in April–May for post-irradiation examination.
Read all positive updates
Company Guidance
Lightbridge’s guidance focused on an accelerated, milestone-driven development program over the next two to three years: recruit additional personnel across disciplines; continue ATR irradiation testing (irradiation began Nov 2025) using the FAST method with 26%–30% enriched U‑Zr coupons to accelerate burnup; remove the initial partially irradiated samples in the April–May timeframe for post‑irradiation examination this year; refine the phenomena identification and ranking table and fuel qualification plan; begin NRC engagement this year; further develop the co‑extrusion process for rodlets and full‑length rods; select a site and initial deployment plan for an expandable fuel facility; and complete thermal‑hydraulics modeling and experiments to confirm burnout, critical heat flux and other key parameters (INL scope expanded with four new projects and three TopFuel papers presented). Financially, management reported approximately $201.9 million in cash and cash equivalents as of 12/31/2025 (up from ~$40.0 million a year earlier), ~$14.3 million of operating cash used in FY2025, ~$176.0 million in net proceeds raised from aftermarket equity, ~$3.6 million of interest income (vs ~$1.3 million prior year), and a debt‑free balance sheet with no convertible securities, which they said provides an extended runway to execute these plans; market context cited included ~18% of U.S. electricity from nuclear in 2024, ~440 operable reactors (~400 GW), 70 under construction and >120 in advanced planning, and policy goals to materially expand capacity by 2050.Lightbridge Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
58
Neutral
Cash Flow
24
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -11.77M | -19.58M | -11.79M | -9.04M | -7.79M | -8.00M |
| Net Income | -21.15M | -19.58M | -11.79M | -7.91M | -7.50M | -7.84M |
Balance Sheet | ||||||
| Total Assets | 218.94M | 203.83M | 40.95M | 29.40M | 29.47M | 24.96M |
| Cash, Cash Equivalents and Short-Term Investments | 215.67M | 201.86M | 39.99M | 28.60M | 28.90M | 24.75M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.29M | 847.45K | 424.58K | 486.33K | 350.33K | 171.52K |
| Stockholders Equity | 217.65M | 202.99M | 40.53M | 28.91M | 29.12M | 24.79M |
Cash Flow | ||||||
| Free Cash Flow | -15.76M | -14.28M | -9.49M | -6.49M | -6.77M | -11.05M |
| Operating Cash Flow | -15.75M | -14.28M | -9.49M | -6.48M | -6.76M | -11.04M |
| Investing Cash Flow | -18.14K | -10.53K | 0.00 | -640.00 | -6.64K | -16.02K |
| Financing Cash Flow | 174.51M | 176.16M | 20.89M | 6.18M | 10.92M | 14.27M |
Lightbridge Technical Analysis
Positive
15.17
Price Trends
12.04
Positive
13.89
Negative
15.82
Negative
Market Momentum
0.01
Negative
60.31
Neutral
79.08
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LTBR, the sentiment is Positive. The current price of 15.17 is above the 20-day moving average (MA) of 11.05, above the 50-day MA of 12.04, and below the 200-day MA of 15.82, indicating a neutral trend. The MACD of 0.01 indicates Negative momentum. The RSI at 60.31 is Neutral, neither overbought nor oversold. The STOCH value of 79.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for LTBR.
Lightbridge Risk Analysis
Lightbridge disclosed 2 risk factors in its most recent earnings report. Lightbridge reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 1 New Risks
Lightbridge Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $1.27B | -100.04 | 135.79% | 6.02% | 3.37% | 269.63% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | $722.62M | -4.17 | -26.54% | ― | 48.29% | 11.56% | |
52 Neutral | $1.39B | -10.09 | -62.42% | ― | 37.91% | 40.36% | |
51 Neutral | $738.94M | -7.26 | -23.87% | ― | 7.98% | 6.11% | |
49 Neutral | $398.30M | -13.46 | -15.31% | ― | ― | 4.53% | |
46 Neutral | $1.36B | -1.53 | -153.56% | ― | 25572.84% | 35.09% |
* Industrials Sector Average
LTBR
Lightbridge
13.05
3.71
39.72%
ENR
Energizer Holdings
19.58
-5.66
-22.42%
FCEL
Fuelcell Energy
13.00
8.92
218.63%
TE
T1 Energy
4.89
3.61
282.03%
ENVX
Enovix
6.40
0.26
4.23%
SLDP
Solid Power
3.35
2.25
204.55%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.